Interestingly, the SMARCB1/INI1-/p53+ tumor group is closely correlated with very short survival and liver metastases when compared with other SMARCB1/INI1/p53 combinations, demonstrating a cooperative effect of both genes in restraining cancer aggressiveness in CRC advanced stages [12]. Here, TP53 is linked to cancer.